This HTML5 document contains 100 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37013066
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel wissenschaftlicher Artikel vedecký článok научни чланак articolo scientifico scientific article published on September 2008 videnskabelig artikel wetenschappelijk artikel article scientifique наукова стаття, опублікована у вересні 2008 artículu científicu espublizáu en 2008 bilimsel makale مقالة علمية نشرت في سبتمبر 2008 artigo científico article científic vědecký článek
p:P577
wds:Q37013066-CAEB3EE9-D6A3-429A-B15E-9B37DA1449D4
wdt:P577
2008-09-01T00:00:00Z
p:P2860
wds:Q37013066-A953BEB9-D4B1-41F8-9170-60BDDDD1DA00 wds:Q37013066-BB14EADE-B2D0-4BB7-8AE3-E9EC6A0BF1CF wds:Q37013066-E6EE8191-0589-4418-A7B8-3F6ABD485D71 wds:Q37013066-36D883D2-83FB-427F-9462-5F1714CC05F7 wds:Q37013066-4C03EF0B-AFCF-4262-A4E2-24CAA37CA265 wds:Q37013066-4DA95EF7-91C9-484B-A3D6-535A71449F70 wds:Q37013066-50E60BFA-8543-4549-94A4-6D5103EAD5A7 wds:Q37013066-876DE1F9-CC61-4643-81BA-91979848FD9F wds:Q37013066-A0A01690-8AFF-4D64-BC08-ED21DEFF9C3E wds:Q37013066-A3C4AF7D-98AF-4894-8A1D-9A4D16CDF975 wds:Q37013066-6007479B-88DF-4B1F-A8BB-8186E3FFFDC9 wds:Q37013066-6533763A-B3EE-46B8-9F82-63FBA481E3F4 wds:Q37013066-6579D3BB-76B6-4DDC-B482-DFFD4281B091 wds:Q37013066-F20A812A-71C1-4F9E-89E7-CFA445DE77B5 wds:Q37013066-F798BFFD-2200-43EA-A1CD-F2C41732A6CE
wdt:P2860
wd:Q35787493 wd:Q35578563 wd:Q28298574 wd:Q77531857 wd:Q52266832 wd:Q35989491 wd:Q78778794 wd:Q74198793 wd:Q73281256 wd:Q35849533 wd:Q74389162 wd:Q77974916 wd:Q35849064 wd:Q36713565 wd:Q33898254
p:P2093
wds:Q37013066-E14E1D8B-3519-4ED1-9929-6CCBDEB69704 wds:Q37013066-64F5EED2-CDA0-4E3E-8519-333C7B34E5A8 wds:Q37013066-5C17F7BE-4C56-4422-AB23-5F14FCB7D541 wds:Q37013066-5956D465-2B8E-4480-AA31-B17FB2C6228F
wdt:P2093
James L M Ferrara John E Levine Todd DeFor Daniel J Weisdorf
rdfs:label
Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT). Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT). Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).
skos:prefLabel
Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT). Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT). Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).
schema:name
Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT). Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT). Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).
p:P50
wds:Q37013066-7382859D-AA22-4C25-8336-2526A56DEF47
wdt:P50
wd:Q62070764
p:P1476
wds:Q37013066-825A5396-9220-49D8-BF67-61E1757E0C0E
wdt:P1476
Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).
p:P304
wds:Q37013066-EEC97F9F-409B-42F7-B5F8-595BDEE38864
wdt:P304
1017-1021
p:P31
wds:Q37013066-A6DBF4D7-0256-4038-9730-767ACFC8D768
wdt:P31
wd:Q13442814
p:P921
wds:Q37013066-16A6BBF1-119D-4B85-A29C-9C584FB6395F wds:Q37013066-300291AD-F053-43AE-94E3-44B4BADA1275 wds:Q37013066-E62BAA83-CE34-4A12-9ADF-AA36ABC0B155 wds:Q37013066-B8F7EA29-457E-4592-B264-AE6F8A09BC4B
wdt:P921
wd:Q108853737 wd:Q269829 wd:Q42824440 wd:Q5452194
p:P698
wds:Q37013066-70280E78-AAB9-4DB8-A0A6-89D77FC27599
wdtn:P698
n11:18721764
wdt:P698
18721764
p:P1433
wds:Q37013066-732A80A9-7FBD-4C16-8805-89B6A9AF5076
wdt:P1433
wd:Q15754328
p:P433
wds:Q37013066-798CC059-56C1-4BE1-87FC-327AB58CF43E
p:P478
wds:Q37013066-516E5568-03CA-486D-BE7F-1F76338DB773
wdt:P433
9
wdt:P478
14
p:P356
wds:Q37013066-69B0FD50-2A26-4398-AB4C-D8FB271FC150
wdtn:P356
n12:J.BBMT.2008.06.013
wdt:P356
10.1016/J.BBMT.2008.06.013
p:P8608
wds:Q37013066-232319AF-E3C7-4DD6-8A1D-8184657731DD
wdt:P8608
release_djtpezxygvdpbkgpzr7xoenfui
p:P5875
wds:Q37013066-98ECC493-8D37-44E7-B793-502B108C3478
wdt:P5875
23188650
p:P932
wds:Q37013066-18C50806-F789-4AE4-9FF4-8A3C1E5574C8
wdt:P932
2601713